By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - At this year’s RSNA more PACS ...
December 6, 2007 – Patients treated with a rotablator drill less risk of perforation than those treated with the excimer ...
December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 6, 2007 - The first commercial implant of the Mitroflow Aortic Pericardial Heart Valve in the U.S. was ...
By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - More so than in previous years ...
December 6, 2007 - Boston Scientific Corp. welcomed the recommendation of a FDA advisory panel to approve with ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Starion Instruments' TLS3 Tissue Ligating Shears feature Starion’s proprietary thermal welding technology, focusing ...
December 5, 2007 - Bristol-Myers Squibb will divest its medical imaging division as part of an initiative to maximize ...
December 5, 2007 - The United Kingdom's Department of Health said today it will begin a new stroke strategy in which ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 4, 2007- Berlin Heart announced the first patient enrollment in the prospective IDE study for its EXCOR Paediatric VAD, a mechanical cardiac support system for critically ill pediatric patients suffering from severe heart failure.
December 4, 2007 - SRSsoft today announced the Cardiovascular Institute of the South (CIS) has selected SRSsoft Clinical ...
December 4, 2007 - In general, drug-eluting stents (DES) achieve better results than bare-metal stents do, U.S ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 4, 2007 – The Impella 2.5, a catheter-based heart pump device, supports high-risk patient’s weakened heart in ...
December 4, 2007 - Patients treated with Abbott Laboratories Inc.’s experimental drug-coated heart stent had low rates ...
December 4, 2007 - ELA Medical Inc. intiated U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications), which will evaluate therapies and advanced algorithms in optimizing treatment and managing ICD patients.